CBD MediHaze Feminized

Open a jar of properly cured CBD MediHaze and the first impression is unmistakably bisabolol — a layered aromatic experience that refuses easy categorisation. Beneath this primary note, myrcene introduces a deep earthy foundation that emerges mid-palate. This 59/41 cbd tests at 4% THC, but the sensory journey is what distinguishes CBD MediHaze from other cultivars at comparable potency. Think of it like comparing a single-origin wine to a blended table variety — the numbers might overlap, but the experience diverges sharply.

Growing CBD MediHaze for maximum terpene expression requires deliberate choices that differ from growing purely for yield. The Bisabolol/Myrcene/Caryophyllene profile responds particularly well to organic living soil — the microbial activity in a well-established no-till bed creates secondary metabolites that synthetic nutrients simply cannot replicate. Australian growers have access to excellent local compost and worm casting suppliers that make this approach practical.

During the 9-11 weeks flowering period, avoid foliar sprays after week 2 — anything deposited on developing trichomes compromises the aromatic purity at harvest. Temperature manipulation in the final three weeks profoundly influences which terpenes dominate the cured flower: cooler night temperatures (16-18°C) amplify bisabolol expression, whilst warmer finishes preserve the lighter caryophyllene top notes.

The cure is where most Australian growers leave flavour on the table. After a 10-14 day hang dry at 15-18°C and 55-60% relative humidity (a challenge in Australian summers — a climate-controlled room or wine fridge set to 16°C works brilliantly), transfer to glass jars and burp twice daily for the first fortnight. The myrcene secondary notes that make this strain genuinely special only emerge after 21-28 days of jar curing. Patience transforms a good flower into a remarkable one.

Indoor yield: 450-550g/m². Outdoor yield: 400-600g/plant. Plant height: Short-Medium (60-105cm). Difficulty: intermediate.

The sensory arc of CBD MediHaze unfolds in stages. Initial inhalation at 4% THC brings a complex aromatic wave that shifts with each breath. The euphoric, focused, calm effects emerge within minutes, presenting as a simultaneous head-and-body experience. Mental clarity remains intact whilst the muscles release tension progressively. This dual action makes it adaptable — a lighter dose suits afternoon tasks, a heavier dose transitions seamlessly into evening relaxation. The myrcene secondary terpene adds a distinct layer: additional body depth that reinforces the physical dimension.

Primary: Bisabolol · Secondary: Myrcene · Tertiary: Caryophyllene. This particular terpene trio appears frequently in award-winning cultivars and produces a nose that most Australian growers find immediately appealing when jars are first opened after curing. The bisabolol dominance anchors the aroma, myrcene provides mid-range character, and caryophyllene contributes a subtle background note that distinguishes this strain from others sharing the same primary terpene.

Who grows CBD MediHaze successfully? Indoor growers seeking full control over their harvest timeline. Outdoor cultivators who want to decide exactly when flowering begins. Anyone with the space and patience to vegetate this plant to its full potential before triggering bloom. Difficulty is rated intermediate, meaning a moderate learning curve that rewards attention without demanding laboratory-grade conditions. Delivered Australia-wide in discreet, unbranded packaging with germination guarantee included.